QS 11

CAS No. 944328-88-5

QS 11( QS11 | QS-11 | QS 11 )

Catalog No. M17682 CAS No. 944328-88-5

QS 11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 73 In Stock
25MG 150 In Stock
50MG 221 In Stock
100MG 333 In Stock
200MG 456 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    QS 11
  • Note
    Research use only, not for human use.
  • Brief Description
    QS 11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor.
  • Description
    QS 11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.(In Vitro):QS11 binds and inhibits the GTPase activating protein of ARFGAP1, suggesting that QS11 modulates Wnt/β-catenin signaling through an effect on protein trafficking.QS11 (2.5 μM) activates the Super(8X)TOPFlash reporter 200-fold in the presence of Wnt-3a conditioned medium, whereas Wnt-3a treatment alone increases reporter activity 40-fold.QS11 shows potent activity (EC50=0.5 μM) with little cytotoxicity toward HEK293 and human primary fibroblast cells.QS11 effectively reduces in vitro migration of metastatic human breast cancer cells.
  • In Vitro
    QS11 binds and inhibits the GTPase activating protein of ARFGAP1, suggesting that QS11 modulates Wnt/β-catenin signaling through an effect on protein trafficking.QS11 (2.5 μM) activates the Super(8X)TOPFlash reporter 200-fold in the presence of Wnt-3a conditioned medium, whereas Wnt-3a treatment alone increases reporter activity 40-fold.QS11 shows potent activity (EC50=0.5 μM) with little cytotoxicity toward HEK293 and human primary fibroblast cells.QS11 effectively reduces in vitro migration of metastatic human breast cancer cells.
  • In Vivo
    ——
  • Synonyms
    QS11 | QS-11 | QS 11
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    ARFGAP1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    944328-88-5
  • Formula Weight
    567.7
  • Molecular Formula
    C36H33N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL 176.16 mM; H2O : < 0.1 mg/mL
  • SMILES
    OC[C@H](Cc1ccccc1)Nc1c2c(n(Cc3ccc(c4ccccc4)cc3)cn2)nc(Oc2ccc3CCCc3c2)n1
  • Chemical Name
    (2S)-2-[[2-(2,3-Dihydro-1H-inden-5-yloxy)-9-[(4-phenylphenyl)methyl]purin-6-yl]amino]-3-phenylpropan-1-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Emre N., et al. A chemical approach to stem cell biology. Curr Opin Chem Biol. 2007 Jun;11(3):252-8.
molnova catalog
related products
  • Trilaciclib hydrochl...

    Trilaciclib hydrochloride is an inhibitor of CDK4/6 (IC50s: 1 nM and 4 nM for CDK4 and CDK6).Incubation with Trilaciclib hydrochloride (G1T28) for 24 hours can induce a strong G1 cell cycle arrest (time=0). Cells have re-entered the cell cycle and demonstrate cell-cycle kinetics similar to untreated control cells By 16 hours after Trilaciclib hydrochloride washout.

  • BAY-958

    BAY-958 (BAY958, LDC526)?is a potent, selective PTEFb/CDK9 inhibitor with IC50 of 5 nM against CDK9/CyclinT1.

  • HQ461

    HQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death.